$3M Gene Therapy—With a Catch - Top_Thought_Leaders - MDSpire

$3M Gene Therapy—With a Catch

Medicaid is testing a pay-for-performance deal that makes drugmakers refund millions if new sickle cell gene therapies fail.

  • By

  • Phil Galewitz

  • January 21, 2026

  • 8 min

Share

Top Thought Leaders in General Medicine

Brief introduction explaining scope and methodology.

Original Source(s)

$3M Gene Therapy—With a Catch

  • by Phil Galewitz

  • January 21, 2026

Related Content

Preop Cognitive Impairment Tied to TKA Delirium

Older patients with documented cognitive impairment also experienced greater postoperative functional decline following elective total knee arthroplasty

RA Prescribing Patterns Shift Over 15 Years

An aging Japanese cohort with rheumatoid arthritis saw increasing use of targeted synthetic therapies as glucocorticoid use declined.

Mutational Signatures May Define Oral Cancers

Researchers identified endogenous mutational and immune-response patterns in oral cancers arising without exposure to tobacco, alcohol, or human papillomavirus infections.